| P2093 | author name string | Eiji Kita | |
| | Fumiko Nishikawa | |
| | Nobutaka Higashi | |
| | Hiroko Harada | |
| P2860 | cites work | The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 | Q28185796 |
| | Salmonella typhimurium translocates flagellin across intestinal epithelia, inducing a proinflammatory response | Q28345391 |
| | Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic | Q33546865 |
| | Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA. | Q34234171 |
| | A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells | Q34257127 |
| | Isolation and purification of human large bowel mucosal lymphoid cells: effect of separation technique on functional characteristics | Q34476526 |
| | Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. | Q36231002 |
| | Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells | Q36356413 |
| | Clinical and field trials with attenuated Salmonella typhi as live oral vaccines and as "carrier" vaccines | Q37804064 |
| | Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation | Q40797037 |
| | Characterization of CD4+ T cell responses during natural infection with Salmonella typhimurium | Q40908028 |
| | Use of quantitative polymerase chain reaction to quantitate cytokine messenger RNA molecules | Q41599371 |
| | Immunostimulatory sequence oligodeoxynucleotide: A novel mucosal adjuvant | Q41726256 |
| | Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues | Q41850548 |
| | Immunogenic dialyzable factor derived from a ribosomal fraction of Salmonella typhimurium III. Analysis of resistance induced by dialyzable factors | Q45223674 |
| | Flagellin, a novel mediator of Salmonella-induced epithelial activation and systemic inflammation: I kappa B alpha degradation, induction of nitric oxide synthase, induction of proinflammatory mediators, and cardiovascular dysfunction | Q50117610 |
| | The full expression of the ity phenotype in ityr mice requires C3 activation by Salmonella lipopolysaccharide | Q50127983 |
| | LT(R192G), a non-toxic mutant of the heat-labile enterotoxin of Escherichia coli, elicits enhanced humoral and cellular immune responses associated with protection against lethal oral challenge with Salmonella spp. | Q50131343 |
| | Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi | Q50146372 |
| | Separate transfer of mouse protection and delayed-type hypersensitivity with Salmonella typhimurium transfer factor | Q50207652 |
| | Immunogenic dialyzable factor derived from a ribosomal fraction of Salmonella typhimurium. I. Preparation of the protective dialyzable factor from the ribosomal fraction by the freeze-thaw procedure | Q50212459 |
| P433 | issue | 12 | |
| P304 | page(s) | 891-905 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Microbiology and Immunology | Q15767399 |
| P1476 | title | Development of a mucosal complex vaccine against oral Salmonella infection in mice | |
| P478 | volume | 46 | |